Seaport Res Ptn Brokers Decrease Earnings Estimates for Aspen Aerogels, Inc. (NYSE:ASPN)

Aspen Aerogels, Inc. (NYSE:ASPN) – Stock analysts at Seaport Res Ptn dropped their Q2 2025 earnings estimates for shares of Aspen Aerogels in a research report issued on Monday, May 6th. Seaport Res Ptn analyst T. Curran now anticipates that the construction company will earn $0.15 per share for the quarter, down from their previous forecast of $0.19. The consensus estimate for Aspen Aerogels’ current full-year earnings is $0.03 per share. Seaport Res Ptn also issued estimates for Aspen Aerogels’ Q3 2025 earnings at $0.19 EPS and FY2025 earnings at $0.78 EPS.

Aspen Aerogels (NYSE:ASPN) last announced its earnings results on Tuesday, February 13th. The construction company reported ($0.01) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.12) by $0.11. Aspen Aerogels had a negative net margin of 10.73% and a negative return on equity of 6.35%. The company had revenue of $84.22 million during the quarter, compared to analyst estimates of $83.82 million. During the same period in the previous year, the business posted ($0.20) earnings per share.

Several other analysts have also issued reports on the company. Piper Sandler boosted their price target on Aspen Aerogels from $20.00 to $29.00 and gave the company an “overweight” rating in a report on Friday, May 3rd. B. Riley increased their target price on shares of Aspen Aerogels from $24.00 to $30.00 and gave the stock a “buy” rating in a report on Friday, May 3rd. Canaccord Genuity Group raised their target price on shares of Aspen Aerogels from $18.00 to $28.00 and gave the stock a “buy” rating in a research note on Friday, May 3rd. Roth Mkm reiterated a “buy” rating and issued a $22.00 price target on shares of Aspen Aerogels in a research report on Tuesday, April 30th. Finally, HC Wainwright raised their price objective on shares of Aspen Aerogels from $20.00 to $25.00 and gave the company a “buy” rating in a research report on Friday, May 3rd. One research analyst has rated the stock with a sell rating and six have issued a buy rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $25.17.

Aspen Aerogels Trading Up 1.4 %

Shares of ASPN stock opened at $26.64 on Wednesday. Aspen Aerogels has a 1 year low of $5.32 and a 1 year high of $27.09. The firm has a fifty day moving average price of $17.27 and a 200-day moving average price of $14.13. The company has a market cap of $2.03 billion, a price-to-earnings ratio of -60.55 and a beta of 1.97. The company has a debt-to-equity ratio of 0.24, a current ratio of 4.01 and a quick ratio of 3.29.

Insider Activity

In other news, SVP Corby C. Whitaker sold 55,159 shares of the firm’s stock in a transaction on Monday, May 6th. The shares were sold at an average price of $25.01, for a total transaction of $1,379,526.59. Following the sale, the senior vice president now directly owns 131,533 shares in the company, valued at approximately $3,289,640.33. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 4.30% of the company’s stock.

Hedge Funds Weigh In On Aspen Aerogels

Several institutional investors have recently bought and sold shares of ASPN. Banque Cantonale Vaudoise grew its stake in shares of Aspen Aerogels by 37.5% in the 1st quarter. Banque Cantonale Vaudoise now owns 4,593 shares of the construction company’s stock worth $81,000 after buying an additional 1,252 shares in the last quarter. McAdam LLC purchased a new position in shares of Aspen Aerogels in the 4th quarter worth $191,000. Mirae Asset Global Investments Co. Ltd. grew its stake in shares of Aspen Aerogels by 71.4% in the 3rd quarter. Mirae Asset Global Investments Co. Ltd. now owns 23,052 shares of the construction company’s stock worth $198,000 after buying an additional 9,601 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank grew its stake in shares of Aspen Aerogels by 38.5% in the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 12,971 shares of the construction company’s stock worth $205,000 after buying an additional 3,607 shares in the last quarter. Finally, Cornerstone Investment Partners LLC purchased a new position in shares of Aspen Aerogels in the 4th quarter worth $230,000. 97.64% of the stock is owned by hedge funds and other institutional investors.

About Aspen Aerogels

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.